FASN-IN-3

FASN-IN-3 is a fatty acid synthase (FASN) inhibitor extracted from patent US20170119786A1, compound 242A[1].

Product Specifications

CAS Number

[2097262-60-5]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Fatty Acid Synthase (FASN)

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/Heterocyclic_modulators_1.html

Purity

98.06

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

N#CC1=CC=C(C2CN(C(C3=CC(C4=C(C)C(C)=NN4)=C(C)C=C3C)=O)C2)C=C1

Molecular Formula

C24H24N4O

Molecular Weight

384.47

Precautions

H302, H315, H319, H335

References & Citations

[1]Buckley, Douglas I, et al. HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS. US20170119786A1

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

AMM20250VCF 100 µg

FHIT Mouse Monoclonal Antibody [Clone ID: LBI1D7]

View Details

C222-25MG 25 mg

Cyclo (L-Pro-L-Tyr)

View Details

LH13420V 100 µg

VNN2 (NM_078488) Human Over-expression Lysate

View Details

OM621561 96 Strip Well

Bovine GDNF family receptor alpha 2 ELISA Kit

View Details

QM25754S 200 Tests

Mouse Fbxw2 qPCR Primer Pair

View Details

PA12124-01 50 μL

Rabbit Anti-Human SYN3 pAb

View Details